2,131
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Gold nanoparticle–oligonucleotide conjugate to detect the sequence of lung cancer biomarker

, , , &
Pages 1417-1423 | Received 01 Feb 2015, Accepted 17 Mar 2015, Published online: 17 Apr 2015

References

  • Ali MA, Eldin TAS, Moghazy GME, Tork IM, Omara II. 2014. Detection of E. coli O157: H7 in feed samples using gold nanoparticles sensor. Int J Curr Microbiol App Sci. 3:697–708.
  • Baptista P, Pereira E, Eaton P, Doria G, Miranda A, Gomes IP, et al. 2008. Gold nanoparticles for the development of clinical diagnosis methods. Anal Bioanal Chem. 391:943–950.
  • Dan’ko V, Michailovska K, Indutnyi I, Shepeliavyi P. 2014. Photoluminescence decay rate of silicon nanoparticles modified with gold nanoislands. Nanoscale Res Lett. 9:165.
  • Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2014a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol.1–13.
  • Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2014b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol.1–11.
  • Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, et al. 2014a. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 9:1–13.
  • Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A. 2014b. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol.1–11.
  • Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. 2007. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2:706–714.
  • Hill HD, Mirkin CA. 2006. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat Protoc. 1:324–336. http://www.digimizer.com/index.php.
  • Huang X, Jain PK, El-Sayed IH, El-Sayed MA. 2007. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond). 2:681–693.
  • Jiang S, Win KY, Liu S, Teng CP, Zheng Y, M- Han Y. 2013. Surface-functionalized nanoparticles for biosensing and imaging-guided therapeutics. Nanoscale. 5:3127–3148.
  • Kim JH, Paek KY, Choi K, T- Kim D, Hahm B, Kim K-T, Jang SK. 2003. Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol Cell Biol. 23:708–720.
  • Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa VM, et al. 2010. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun. 393:649–655.
  • Li Y, Zhang Z, Liu F, Vongsangnak W, Jing Q, Shen B. 2012. Performance comparison and evaluation of software tools for microRNA deep-sequencing data analysis. Nucleic Acids Res. 40:4298–4305.
  • McGinnis S, Madden TL. 2004. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 32: W20–W25.
  • Mellatyar H, Akbarzadeh A, Rahmati M, Ghalhar MG, Etemadi A, Nejati-Koshki K, et al. 2014. Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pac J Cancer Prev. 15:8693–8698.
  • Mi H-Y, Li Z, Turng LS, Sun Y, Gong S. 2014. Silver nanowire/thermoplastic polyurethane elastomer nanocomposites: Thermal, mechanical, and dielectric properties. Mater Design. 56:398–404.
  • Mikhlin Y, Karacharov A, Likhatski M, Podlipskaya T, Zubavichus Y, Veligzhanin A, Zaikovski V. 2011. Submicrometer intermediates in the citrate synthesis of gold nanoparticles: new insights into the nucleation and crystal growth mechanisms. J Colloid Interface Sci. 362:330–336.
  • Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, Camargo ERD, Barbosa DB. 2009. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents. 34:103–110.
  • Morel NM, Holland JM, van der Greef J, Marple EW, Clish C, Loscalzo J, Naylor S. 2004. Primer on medical genomics Part XIV: introduction to systems biology—a new approach to understanding disease and treatment. Mayo Clin Proc. 79:651–658.
  • Ojea-Jiménez I, Romero FM, Bastús NG, Puntes V. 2010. Small gold nanoparticles synthesized with sodium citrate and heavy water: insights into the reaction mechanism. J Phys Chem C. 114: 1800–1804.
  • Reynolds RA, Mirkin CA, Letsinger RL. 2000. Homogeneous, nanoparticle-based quantitative colorimetric detection of oligonucleotides. J Am Chem Soc. 122:3795–3796.
  • Sato A, Sueoka-Aragane N, Saitoh J, Komiya K, Hisatomi T, Tomimasu R, et al. 2008. Establishment of a new method, transcription–reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer. J Cancer Res Clin Oncol. 134:1191–1197.
  • Seidi K, Eatemadi A, Mansoori B, Jahanban-Esfahlan R, Farajzadeh D. 2014. Nanomagnet-Based detoxifying machine: an alternative/complementary approach in hiv therapy. J AIDS Clin Res. 5:2.
  • Shawky SM, Bald D, Azzazy HME. 2010. Direct detection of unamplified hepatitis C virus RNA using unmodified gold nanoparticles. Clin Biochem. 43:1163–1168.
  • Soskolne CL. 1997. Ethical, social, and legal issues surrounding studies of susceptible populations and individuals. Environ Health Perspect. 105:837.
  • Taton TA. 2002. Preparation of gold nanoparticle–DNA conjugates. Curr Protoc Nucleic Acid Chem. 12–12.
  • Veigas B, Doria G, Baptista PV. 2012. Nanodiagnostics for tuberculosis. In: Cardona P-J, Ed. Understanding Tuberculosis-Global Experiences and Innovative Approaches to the Diagnosis. InTech, pp. 257–276.
  • Zhou J, Mulshine JL, Unsworth EJ, Scott FM, Avis IM, Vos MD, Treston AM. 1996. Purification and characterization of a protein that permits early detection of lung cancer Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem. 271:10760–10766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.